AstraZeneca | Resultado Líquido



Net Income Alterar Data
AbbVie USD 1.29B 1.31B 2025-03
Alcon AG USD 350M 66M 2025-03
Almirall EUR 21.6M 26.84M 2025-03
Amgen USD 1.73B 1.1B 2025-03
argenx SE USD 169.47M 604.69M 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Autolus Therapeutics Ltd -70161000 42.55M 2025-03
Bayer EUR 1.3B 1.63B 2025-03
Biogen USD 240.5M 26.2M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Fresenius EUR 229M 11M 2025-03
Fresenius Medical Care EUR 151M 84.1M 2025-03
Galapagos EUR -105748000 47.66M 2025-06
Genmab DKK 195M 3.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
GRIFOLS EUR 59.72M 9.24M 2025-03
Haleon 231M 254M 2024-12
Hikma Pharmaceutical USD 133M 93M 2024-12
Indivior 48M 11M 2025-03
Lonza CHF 307M 22M 2024-12
Merck EUR 735M 68M 2025-03
Merck USD 5.08B 1.34B 2025-03
Novartis USD 4.02B 418M 2025-06
Orion EUR 82.5M 21.3M 2025-06
Pfizer USD 2.97B 2.56B 2025-03
Philips EUR 75M 410M 2025-03
Recordati EUR 125.04M 12.01M 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
UCB EUR 857M 649M 2024-12


AstraZeneca Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.